OTCMKTS:ARYC Arrayit (ARYC) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisChartSEC FilingsBuy This Stock About Arrayit Stock (OTCMKTS:ARYC) 30 days 90 days 365 days Advanced Chart Get Arrayit alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume30,500 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Arrayit Corporation (OTCMKTS: ARYC) is a biotechnology company specializing in the development and manufacture of microarray-based solutions for genomics and proteomics research. The company’s core offerings include high-density DNA and protein microarray substrates, reagents, and integrated platforms designed to support gene expression profiling, mutation analysis, biomarker discovery and molecular diagnostics. By combining precision surface chemistry with advanced instrumentation, Arrayit provides researchers with tools for high-throughput screening and data generation in both academic and commercial settings. In addition to standard microarray slides, Arrayit’s product portfolio features custom array design services, automated hybridization and imaging systems, and proprietary data analysis software. Their turnkey approach enables life science organizations and pharmaceutical companies to accelerate drug discovery, toxicogenomics studies and clinical research workflows. The company emphasizes compatibility with established laboratory infrastructure and offers technical support for protocol optimization and assay development. Headquartered in Sunnyvale, California, Arrayit serves a global customer base that spans North America, Europe and Asia Pacific. The company collaborates with universities, research institutes and industry partners to address evolving needs in personalized medicine, translational research and diagnostic assay development. Arrayit’s commitment to innovation in microarray technology positions it as a specialist supplier in the fast-growing field of molecular profiling and precision health.AI Generated. May Contain Errors. Read More Receive ARYC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Arrayit and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ARYC Stock News HeadlinesArrayit CorpMay 24, 2024 | thestreet.comaryc.pk - Arrayit Corp | Stock Price & Latest News | ReutersDecember 26, 2022 | reuters.comA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boom. For retirees, that could mean a way to generate reliable monthly income—without the outdated 4% withdrawal rule, risky trading, or high-fee annuities. If you’re ready to stop worrying about money running out and start enjoying the freedom to cover expenses, treat loved ones, and live life on your terms, this may be exactly what you’ve been waiting for.September 15 at 2:00 AM | Investors Alley (Ad)Insights on the IoT Healthcare Global Market to 2028 - North America is Projected to Hold a Significant S - BenzingaSeptember 21, 2022 | benzinga.comMicroarray Market to Reach $8.4 Billion, Globally, by 2031 at 7.8% CAGR: Allied Market Research - BloombergSeptember 14, 2022 | bloomberg.comWednesday Morning News Roundup - SFGATESeptember 7, 2022 | sfgate.comCalifornia Biotech Executive Is Guilty in $77 Million Blood-Testing Scheme - The New York TimesSeptember 2, 2022 | nytimes.comFeds Rip Exec's 'Culture Of Lies' As Covid Fraud Trial Wraps - Law360August 30, 2022 | law360.comSee More Headlines ARYC Stock Analysis - Frequently Asked Questions How do I buy shares of Arrayit? Shares of ARYC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Arrayit own? Based on aggregate information from My MarketBeat watchlists, some other companies that Arrayit investors own include Mr. Cooper Group (COOP), Western Alliance Bancorporation (WAL), Pacific Biosciences of California (PACB), WMIH (WMIH), Actinium Pharmaceuticals (ATNM), MICT (MICT) and PolyMet Mining (PLM). Company Calendar Today9/15/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED INSTRUMENTS Sub-IndustryMeasuring And Control Equipment Current SymbolOTCMKTS:ARYC CIK1084507 Webwww.arrayit.com Phone(408) 744-1331Fax408-744-1711Employees7Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (OTCMKTS:ARYC) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arrayit Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arrayit With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.